COPD trials in Australia

In Australia 14 Also abroad 559

14 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
PRA-216 COPD Safety and Biomarker Study
Where
Birtinya, Botany, Camberwell, Campbelltown, Southport
Age
40 years to 80 years
People
40
Run by
Prana Therapies Inc
See details and how to joinNCT07730281
Phase 2Taking people
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Where
Cairns, Nedlands, Norwood, Osborne Park, South Brisbane, Wollongong
Age
40 years and over
People
987 worldwide
Run by
AstraZeneca
See details and how to joinNCT07082738
Phase 3Taking people
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Where
Coffs Harbour, Dunedin, Osborne Park, South Brisbane, Tiwi, Townsville, Traralgon
Age
40 years to 80 years
People
942 worldwide
Run by
Sanofi
See details and how to joinNCT07190222 · EU 2024-518213-25-00
Phase 2/3Taking people
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Where
Clayton, South Brisbane, Spearwood, Westmead
Age
35 years to 80 years
People
1,156 worldwide
Run by
Pfizer
See details and how to joinNCT07363694 · EU 2024-518587-12-00
Phase 1/2Taking people
A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of KIT2014 in Patients With Moderate to Severe COPD
Where
Camberwell, Charlestown, Sydney
Age
40 years to 80 years
People
36
Run by
Kither Biotech Srl
See details and how to joinNCT07668518
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Where
Coffs Harbour, Frankston, Garran, Nedlands, New Lambton, Spearwood, Wollongong, Woodville South
Age
40 years to 80 years
People
990 worldwide
Run by
AstraZeneca
See details and how to joinNCT06878261 · EU 2024-517457-27-00
Phase 3Taking people
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Where
Coffs Harbour, Maroubra, Midland, Westmead
Age
40 years to 80 years
People
961 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06961214 · EU 2024-520417-41-00
Phase 3Taking people
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Where
Birtinya, Cairns, Chermside, Coffs Harbour, Dubbo, Nedlands, Port Macquarie, Spearwood, St Albans, Waitara, Wangaratta
Age
40 years to 80 years
People
5,250 worldwide
Run by
AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00
No phaseTaking people
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Where
Adelaide, Brisbane, Macquarie Park
Age
40 years to 80 years
People
200 worldwide
Run by
Pulmonx Corporation
See details and how to joinNCT06035120
Phase 1Taking people
Inhaled RB042 in Healthy Adult Volunteers, Healthy Adult Smokers and Patients With Chronic Obstructive Pulmonary Disease
Where
Nedlands
Age
18 years to 80 years
People
105
Run by
Atisama Therapeutics
See details and how to joinNCT07285122
Phase 1Taking people
Investigation of Small Mobile Stem Cells (SMS Cells) in Participants With Chronic Obstructive Pulmonary Disease (COPD).
Where
Melbourne
Age
39 years to 69 years
People
18
Run by
SMSbiotech
See details and how to joinNCT06986070
Phase 3Taking people
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Where
Coffs Harbour, Spearwood
Age
40 years to 75 years
People
1,196 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00
Phase 1Taking people
A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
Where
Brisbane, Perth
Age
18 years to 80 years
People
286 worldwide
Run by
Bambusa Therapeutics
See details and how to joinNCT06944925 · EU 2025-523142-28-00
Phase 3Enrolling by invitation
Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
Where
Adelaide, Chermside, Darlinghurst, Fitzroy, Nedlands
Age
20 years to 72 years
People
290 worldwide
Run by
Grifols Therapeutics LLC
See details and how to joinNCT02796937